Clinical Efficacy of Ulinastatin for Treatment of Sepsis With Systemic Inflammatory Response Syndrome
NCT05391789
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
120
Enrollment
OTHER
Sponsor class
Conditions
Sepsis
Interventions
DRUG:
Ulinastatin
DRUG:
Placebo
Sponsor
Huashan Hospital